Bo Long
Impact in
-
- Aquaculture disease management and microbiota
- Immune Response and Inflammation
- Invertebrate Immune Response Mechanisms
- Galectins and Cancer Biology
-
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
- Pancreatic and Hepatic Oncology Research 2
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Zeyuan Yu (4 shared papers)Huinian Zhou (5 shared papers)Xiangyan Jiang (3 shared papers)Zuoyi Jiao (6 shared papers)Long Qin (3 shared papers)Wengui Shi (3 shared papers)Ping Ouyang (2 shared papers)Kaiyu Wang (2 shared papers)
- Journals
- Current Cancer Drug Targets (1 paper)International Journal of Surgery (1 paper)Scientific Reports (1 paper)Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bo Long
13 papers receiving 290 citations
Peers
Comparison fields: 5 of 60
- Immunology 111
- Oncology 100
- Aquatic Science 20
- Endocrinology 14
- Cancer Research 37
Countries citing papers authored by Bo Long
This map shows the geographic impact of Bo Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Long more than expected).
Fields of papers citing papers by Bo Long
This network shows the impact of papers produced by Bo Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Long. The network helps show where Bo Long may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 78 | |
| 2 | 2016 | 55 | |
| 3 | 2019 | 27 | |
| 4 | 2016 | 26 | |
| 5 | 2019 | 25 | |
| 6 | 2022 | 24 | |
| 7 | 2018 | 21 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 10 | |
| 10 | 2018 | 8 | |
| 11 | 2017 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2025 | 1 |
About Bo Long
Bo Long is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Immunology and Molecular Biology, having authored 13 papers that have together received 293 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (3 papers), Peptidase Inhibition and Analysis (3 papers), CAR-T cell therapy research (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Aquaculture disease management and microbiota (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Invertebrate Immune Response Mechanisms (1 paper). The work is most often cited by research in Immunology (111 citations), Oncology (100 citations), Aquatic Science (20 citations), Endocrinology (14 citations) and Cancer Research (37 citations). Bo Long has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zeyuan Yu, Huinian Zhou, Xiangyan Jiang, Zuoyi Jiao, Long Qin, Wengui Shi, Ping Ouyang, Kaiyu Wang, Xiaoli Huang and Weimin Lai. Their work appears in journals such as Current Cancer Drug Targets, International Journal of Surgery, Scientific Reports, Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.